EIF2A and myeloid sarcoma: PERK and CHOP are implicated in the regulation of Th17 inflammatory cytokines, and one study specifically found that inhibiting PERK inhibits Th17 cell differentiation55,56 Targeting the PERK-eIF2α pathway has been reported as an ideal strategy for protecting oligodendrocyte protection in MS, and we show for the first time that GA may be able to57.